Antiepileptic drugs taken during pregnancy may increase risk of impaired development for children

New research suggests that taking antiepileptic drugs during pregnancy increases the risk of the child having impaired brain development.

A team from the University of Birmingham and partners in Australia announced the findings after researching children born to mothers who took sodium valproate (VPA) during pregnancy.

VPA works by stabilising electrical activity in the brain, and so reduces fits. It is commonly used to treat a range of conditions including epilepsy, bipolar depression and migraines.

The evidence, published in Annals of Clinical and Translational Neurology, strongly supports the theory that prenatal exposure to VPA affects ,adding to evidence for increased risk of and neurodevelopmental difficulties – particularly with language skills.

It is the first study to directly examine the neural effects in children of mothers with epilepsy who took VPA during pregnancy.

The results were acquired by comparing high-resolution structural brain scans of seven year old children whose mothers took VPA for during pregnancy, to a control group of children not exposed to the medication.

In those children exposed to VPA, the scans showed an increased cortical thickness in the left and left pericalcarine sulcus. The hemispheric asymmetry usually found in areas of the brain involved in aspects of language processing was also absent.

These regions of the brain are known to be critical in the development of , such as verbal communication.

Dr Amanda Wood, from the University of Birmingham, explained, "This is only a small group, but nonetheless it represents an important first step in understanding how taking VPA during pregnancy might effect a child's brain development."

"VPA remains an important medication for people with epilepsy. What this study really tells us is that further research is required so that all women with epilepsy can make informed decisions about their medication use during pregnancy."

Women taking medications during should always consult their treating doctor before changing their medication.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

US aims for traumatic brain injury clinical trial success

2 hours ago

An unprecedented, public-private partnership funded by the Department of Defense (DoD) is being launched to drive the development of better-run clinical trials and may lead to the first successful treatments for traumatic ...

New learning mechanism for individual nerve cells

8 hours ago

The traditional view is that learning is based on the strengthening or weakening of the contacts between the nerve cells in the brain. However, this has been challenged by new research findings from Lund University in Sweden. ...

User comments